TADDEI, MARIA LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.799
EU - Europa 2.871
AS - Asia 372
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.047
Nazione #
US - Stati Uniti d'America 3.791
PL - Polonia 1.394
IT - Italia 430
SE - Svezia 317
IE - Irlanda 308
HK - Hong Kong 168
UA - Ucraina 123
DE - Germania 96
CN - Cina 83
FI - Finlandia 64
GB - Regno Unito 52
VN - Vietnam 47
JO - Giordania 30
RU - Federazione Russa 29
IN - India 24
CH - Svizzera 20
FR - Francia 12
BE - Belgio 11
ES - Italia 11
TR - Turchia 10
CA - Canada 6
SG - Singapore 6
SC - Seychelles 4
KR - Corea 3
CZ - Repubblica Ceca 2
NL - Olanda 2
EU - Europa 1
HN - Honduras 1
MX - Messico 1
PH - Filippine 1
Totale 7.047
Città #
Warsaw 1.394
Fairfield 636
Ashburn 419
Dublin 308
Chandler 288
Cambridge 265
Woodbridge 262
Seattle 245
Houston 229
Wilmington 214
Jacksonville 185
Florence 170
Altamura 122
Lawrence 113
Hong Kong 108
Ann Arbor 95
Princeton 81
Boardman 62
Boston 55
Buffalo 48
Beijing 44
Dong Ket 41
San Diego 34
Medford 33
Moscow 25
Shanghai 23
Pune 22
New York 20
Kent 19
Falls Church 18
Bern 15
Norwalk 14
Auburn Hills 12
Barcelona 11
Brussels 11
Bremen 10
Dearborn 10
Izmir 9
Andover 8
Milan 8
Phoenix 8
Chieri 6
Singapore 6
Hillsboro 5
Laurel 5
London 5
Redwood City 5
Tappahannock 5
Toronto 5
Berlin 4
Frankfurt Am Main 4
Helsinki 4
Kilburn 4
Verona 4
Arezzo 3
Impruneta 3
Lappeenranta 3
Prescot 3
Rome 3
Washington 3
Castelliri 2
Cedar Knolls 2
Chiswick 2
Dübendorf 2
Los Angeles 2
Lucca 2
Olomouc 2
Parma 2
Reggio Nell'emilia 2
Salerno 2
Seongdong-gu 2
West Jordan 2
Arnsberg 1
Barletta 1
Boca Raton 1
Bologna 1
Brentford 1
Brindisi 1
Calenzano 1
Campi Bisenzio 1
Castelnuovo 1
Chengdu 1
Dietikon 1
Dongguan 1
Groningen 1
Hounslow 1
Islington 1
Jiaxing 1
Kunming 1
Langfang 1
Leawood 1
L’Aquila 1
Mexico City 1
Monsummano Terme 1
Naaldwijk 1
Naples 1
Napoli 1
Neuchâtel 1
Nottingham 1
Nürnberg 1
Totale 5.826
Nome #
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 247
EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase 232
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits 231
Tyrosine-phosphorylated caveolin is a physiological substrate of the low M(r) protein-tyrosine Phosphatase 230
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 226
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 219
The effects of CA IX catalysis products within tumor microenvironment 219
Globular adiponectin activates motility and regenerative traits of muscle satellite cells. 217
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 155
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 133
miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil 132
Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition 125
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 124
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like trait 122
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 122
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression. 116
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 115
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 113
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. 110
Senescent stroma promotes prostate cancer progression: The role of miR-210 109
Down-regulation of platelet-derived growth factor receptor signaling during myogenesis. 105
LMW-PTP is a positive regulator of tumor onset and growth 105
Low Molecular Weight-Protein Tyrosine Phosphatase and Caveolin-1: Interaction and Isoenzyme-Dependent Regulation 103
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 102
INSULIN INHIBITS PLATELET-DERIVED GROWTH FACTOR-INDUCED CELL PROLIFERATION 95
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. 94
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style 94
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells 91
Microenvironment and tumor cell plasticity: An easy way out. 90
Low M(r) phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site 88
Acylphosphatase is involved in differentiation of K562 cells 88
Characterization of a novel nucleolytic activity of acylphosphatases 88
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells. 88
Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness 86
Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity 86
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. 86
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. 84
LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling. 83
The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. 82
Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. 81
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 81
Low molecular weight protein-tyrosine phosphatase controls the rate and the strength of NIH-3T3 cells adhesion through its phosphorylation on tyrosine 131 or 132 81
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin 79
Anoikis: an emerging hallmark in health and diseases. 79
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. 79
Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis 75
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. 75
SRC redox regulation: Again in the frontline. 74
EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells 73
RECIPROCAL METABOLIC REPROGRAMMING THROUGH LACTATE SHUTTLE COORDINATELY INFLUENCES TUMOR-STROMA INTERPLAY. 67
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. 65
null 62
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment 62
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 62
Constitutive expression of interleukin-1beta (IL-1beta) in rat oligodendrocytes. 58
Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting. 57
miR-205 Hinders the Malignant Interplay Between Prostate Cancer Cells and Associated Fibroblasts 56
Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation 55
Targeted DNA oxidation by LSD1-SMAD2/3 primes TGF-β1/ EMT genes for activation or repression 55
New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases 54
Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. 52
Nuclear localization of TRK-A in liver cells. 52
Possible role of both isoforms of acylphosphatase in differentiation and apoptosis in k562 cells 52
Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 48
Role of tyrosine phosphorylation in modulating cancer cell metabolism 45
The miR-27a/FOXJ3 Axis Dysregulates Mitochondrial Homeostasis in Colorectal Cancer Cells 45
Claisened hexafluoro inhibits metastatic spreading of amoeboid melanoma cells 44
Chemoenzymatic Synthesis of Glycopeptides to Explore the Role of Mucin 1 Glycosylation in Cell Adhesion 43
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis 40
The low mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at tyr131 or tyr132 by src kinase. 38
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids 37
Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase. 36
Therapy-induced stromal senescence promoting aggressiveness of prostate and ovarian cancer 28
Transcriptomic analysis of colorectal cancer cells treated with oil production waste products (OPWPs) reveals enrichment of pathways of mitochondrial functionality 27
Studies on the interaction of LMW-PTP with caveolin 24
Insulin strongly inhibits PDGF-induced cell proliferation 21
Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies 18
Metabolic reprogramming in cholangiocarcinoma 16
Targeting of tumor cells by custom antigen transfer: a novel approach for immunotherapy of cancer 11
Mitochondrial oxidative stress due to complex I dysfunction promotes fibroblast activation and melanoma cell invasiveness 10
Blockade of IL-10 signaling ensures mifamurtide efficacy in metastatic osteosarcoma 10
EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts. 9
Metabolic challengers selecting tumor-persistent cells 8
Totale 7.179
Categoria #
all - tutte 20.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019190 0 0 0 0 0 0 0 0 0 0 0 190
2019/20201.579 104 123 55 126 157 181 156 221 162 116 151 27
2020/20211.327 88 103 74 181 66 147 76 102 111 225 59 95
2021/2022638 25 65 66 21 25 26 35 34 25 32 123 161
2022/20231.529 128 319 88 104 109 263 197 92 147 5 43 34
2023/2024675 13 59 80 40 53 123 26 196 10 28 37 10
Totale 7.179